Title:
PHARMACEUTICAL COMPOSITION COMPRISING ANTI-FXI/FXIA ANTIBODY AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/131213
Kind Code:
A1
Abstract:
A pharmaceutical composition comprising an anti-FXI/FXIa antibody and the use thereof. The specific pharmaceutical composition to which the present disclosure relates comprises an anti-FXI/FXIa antibody or an antigen-binding fragment thereof, and a buffer.
Inventors:
SHEN LIJUN (CN)
ZHAO ZHILONG (CN)
LI LEI (CN)
TANG CHENXIANG (CN)
ZHAO ZHILONG (CN)
LI LEI (CN)
TANG CHENXIANG (CN)
Application Number:
PCT/CN2023/070573
Publication Date:
July 13, 2023
Filing Date:
January 05, 2023
Export Citation:
Assignee:
SHANGHAI MABGEN BIOTECH LTD (CN)
International Classes:
C07K16/36; A61K39/00; A61K39/395; C12N15/13
Domestic Patent References:
| WO2022002249A1 | 2022-01-06 | |||
| WO2021127525A1 | 2021-06-24 | |||
| WO2020211674A1 | 2020-10-22 | |||
| WO2020131935A1 | 2020-06-25 | |||
| WO2017203450A1 | 2017-11-30 | |||
| WO2018210230A1 | 2018-11-22 |
Foreign References:
| CN111902427A | 2020-11-06 | |||
| CN110732023A | 2020-01-31 |
Other References:
AL-HORANI RAMI A., AFOSAH DANIEL K.: "Recent advances in the discovery and development of factor XI/XIa inhibitors", MEDICINAL RESEARCH REVIEWS, WILEY SUBSCRIPTION SERVICES, INC., A WILEY COMPANY, US, vol. 38, no. 6, 1 September 2018 (2018-09-01), US , pages 1974 - 2023, XP093076601, ISSN: 0198-6325, DOI: 10.1002/med.21503
Attorney, Agent or Firm:
GE CHENG & CO., LTD (CN)
Download PDF:
Previous Patent: SIDELINK COMMUNICATION METHOD AND APPARATUS
Next Patent: BEAUTY DEVICE CONTROL SYSTEM BASED ON OPTICAL ASSEMBLY, AND BEAUTY DEVICE
Next Patent: BEAUTY DEVICE CONTROL SYSTEM BASED ON OPTICAL ASSEMBLY, AND BEAUTY DEVICE